ArticleFrontiers in oncology2025

HER2-targeted therapy combined with multidisciplinary management in advanced gallbladder cancer: a case report with 90-month survival.

Yulin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.